Characterization of variant alelles of cytochrome CYP2D6 in a Spanish population

Cell Biochemistry and Function

Volumn 24, Issue 5, 2006, Pages 381-385

  Menoyo, Anna ^a   Del Rio, Elisabeth ^a   Baiget, Montserrat ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

CYP2D6; Genetic polymorphism; Spain

Indexed keywords

CYTOCHROME P450 2D6;

ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; ENZYME ACTIVITY; FEASIBILITY STUDY; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SPAIN; WILD TYPE; GENE DUPLICATION; GENETIC PREDISPOSITION; GENETICS; METHODOLOGY; PHARMACOKINETICS; PREDICTION AND FORECASTING;

ALLELES; CYTOCHROME P-450 CYP2D6; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE DUPLICATION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; PHARMACOKINETICS; PHENOTYPE; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PREVALENCE; SPAIN;

EID: 33748624897     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1258     Document Type: Article

References (15)

1. http://www.imm.ki.se/cypalleles
2. Miller SA, Dykes DD, Polesky MF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988; 16: 1215.
3. Sachse C, Brockmöller J, Bauer S, Roots I. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotype consequences. Am J Hum Genet 1997; 60: 284-295.
4. Scarlett L, Madani S, Shen D, Ho R. Development and characterization of a rapid and comprehensive genotyping assay to detect the most common variants in cytochrome P450 2D6. Pharm Res 2000; 17: 242-246.
5. Lovlie R, Daly AK, Molven A, Idle JR, Steen VM. Ultrarapid metabolizers of debrisoquine: characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene. Febs Lett 1996; 392: 30-34.
6. Johansson I, Lundqvist E, Dahl ML, Ingelman-Sundberg M. PCR-based genotyping for duplicated and deleted CYP2D6 genes. Pharmacogenetics 1996; 6: 351-355.
7. Leathart JBS, London SJ, Adams JD, Idle JR, Daly AK. CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians. Pharmacogenetics 1998; 8: 529-542.
8. Masimirembwa CM, Hasler JA. Genetic polymorphism of drug metabolising enzymes in African populations: implications for the use of neuroleptics and antidepressants. Brain Res Bull 1997; 44: 561-571.
9. Griese EU, Zanger UM, Brudermanns U, et al. Assessment of predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population. Pharmacogenetics 1998; 8: 15-26.
10. Agundez J, Martinez C, Ledesma MC, Ladona MG, Ladero JM, Benitez J. Genetic basis for differencies in debrisoquin polymorphism between a Spanish and other white populations. Clin Pharmacol Ther 1994; 55: 412-417.
11. Dahl ML, Johansson I, Bertilsson I, Ingelman-Sundberg M, Sjökvist F. Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis. J Pharmacol Exp Ther 1995; 274: 516-520.
12. Agundez J, Ledesma M, Ladero J, Benitez J. Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population. Clin Pharmacol Ther 1995; 57: 265-269.
13. Agundez J, Ledesma M, Ladero J, Benitez J. Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population. Clin Pharmacol Ther 1995; 57: 265-269.
14. Bernal ML, Sinues B, Johansson I, et al. Ten percent of North Spanish individuals carry duplicated or triplicated CYP2D6 genes associated with ultrrapid metabolism of debrisoquine. Pharmacogenetics 1999; 9: 567-660.
15. Bernal ML, Sinues B, Johansson I, et al. Ten percent of North Spanish individuals carry duplicated or triplicated CYP2D6 genes associated with ultrrapid metabolism of debrisoquine. Pharmacogenetics 1999; 9: 567-660.